About this trial
Purpose of research The purpose of this study was to demonstrate that polyethylene (Vitamin E-containing polyethylene), a newly introduced biomaterial for tibial inserts in hip replacement surgery and widely used clinically, but whose mid- to long-term clinical results are still unknown, is superior to conventional polyethylene in vivo. The aim of this project is to conduct an international multi-center joint research study to determine whether polyethylene wear debris production can be reduced in the future, using an in vivo polyethylene wear debris analysis method that the investigators developed as a method that can provide early feedback.
Eligibility criteria
Qualifiers
Patients undergoing revision hip arthroplasty within the study period
Patients over 20 years old
Patients who have received a sufficient explanation, have sufficient understanding, and have given their free written consent.
Patients who have passed 2 years or more since their first total hip arthroplasty
Disqualifiers
None
Trial design
Treatments tested in this trial
- polyethylene
Treatment groups
Sponsors and collaborators
Osaka Metropolitan University
Lead sponsor
Mayo Clinic
Collaborator
Hospital for Special Surgery, New York
Collaborator
Istituto Ortopedico Rizzoli
Collaborator